BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines scope 3 Cat. 6 — Business Travel (tCO2e)
BeOne Responsible Business & Sustainability Report (ESG)
Latest, FY2025
21,253
Period ended Dec 31, 2025
Change on a year earlier
+20.6%
17,628 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Scope 3 Cat. 6 — Business Travel (tCO2e) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21,253 | +20.6% | 2025 ESG Report ↗ |
| FY2024 | Dec 31, 2024 | 17,628 | +176.3% | 2025 ESG Report ↗ |
| FY2023 | Dec 31, 2023 | 6,380 | -45.1% | 2025 ESG Report ↗ |
| FY2022 | Dec 31, 2022 | 11,621 | – | 2024 ESG Report ↗ |
Cite this data
StockData. (2026). BeOne Medicines Scope 3 Cat. 6 — Business Travel (tCO2e), annual FY2022–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/esg_ghg_s3_trv
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.